Concepedia

Sheri Booten

SB

Statistics

Publications

24

Citations

4.4K

H-Index

19

Active since

2005

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Sahlgrenska University Hospital

Indiana University School of Medicine

University of Gothenburg

University of Oslo

Sheri Booten is an author at Ionis Pharmaceuticals (United States) specializing in antisense rnas, life sciences, and pharmacology.

Publications per year

2005–2022

24

Publications

24

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Christine Esau, Scott Davis, Susan Murray et al. · Cell Metabolism · 2006 · 2.1K citations · Full text

, , +16

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice

Thazha P. Prakash, Mark J. Graham, Jinghua Yu et al. · Nucleic Acids Research · 2014 · 597 citations · Full text

, , +17

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†

Xing Yu, Susan F. Murray, Sanjay K. Pandey et al. · Hepatology · 2005 · 303 citations · Full text

, , +17

Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice

Shuling Guo, Carla Casu, Sara Gardenghi et al. · Journal of Clinical Investigation · 2013 · 215 citations · Full text

, , +17

Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides

Elizabeth J. Ackermann, Shuling Guo, Merrill D. Benson et al. · Amyloid · 2016 · 138 citations

, , +16

1–5 of 24